| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |